In 2004, Gloria Ro Kolb ’94 was leading her first startup, Fossa Medical, which developed therapies for kidney stones, when she learned a startling statistic: one in three women over 30 deals with urinary incontinence. However, it wasn’t until Kolb had three kids that she began to understand the scope of the problem—and the need for a better solution. “I looked into all the treatment options and thought, ‘Oh my gosh, there’s got to be something better,’” she recalls. So she took matters into her own hands by founding the medical-device company Elidah.
Traditional treatments for urinary incontinence in women have been limited to pelvic floor exercises, invasive devices, or—in extreme cases—surgery. Moreover, many women are hesitant to discuss the issue with a doctor. “Women wait so long that it gets harder and harder for them to treat conservatively, and it really does start to affect their quality of life,” Kolb explains.
With Kolb as CEO, the Connecticut-based company has developed Elitone, a noninvasive device composed of a small electrical controller connected to a gel pad. The device, typically worn for 20 minutes four to five days a week, decreases bladder leaks by stimulating and strengthening a woman’s pelvic floor muscles—essentially doing Kegel exercises for her, but longer and stronger than she could, Kolb explains.
Elitone was cleared by the US Food and Drug Administration in 2019 for both prescription and over-the-counter use. “Two-thirds of women won’t talk to their doctor about this—that’s how secret and private it is—so we wanted to reach out to the women directly,” Kolb says. “This is a new and growing category of direct-to-consumer medical devices.”
While FDA approval is a big milestone, Kolb finds the most satisfaction in emails from women describing their return to daily activities like dancing or running. “This is why we do what we do—because it helps,” she says. Now, the company is developing a version of Elitone for the related issue of overactive bladder. It is also investigating whether a similar device can be developed for men.
“MIT is a good foundation for figuring out how to do things well and how to do them on your own,” says Kolb, who majored in mechanical engineering. At Elidah, she has taken on everything from designing and building prototypes to writing patents and regulatory documents. And she is eager for more opportunities to invent as she remains focused on her overarching goal: “Helping as many people as I can with the products that I make.”
This new data poisoning tool lets artists fight back against generative AI
The tool, called Nightshade, messes up training data in ways that could cause serious damage to image-generating AI models.
The Biggest Questions: What is death?
New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.
Rogue superintelligence and merging with machines: Inside the mind of OpenAI’s chief scientist
An exclusive conversation with Ilya Sutskever on his fears for the future of AI and why they’ve made him change the focus of his life’s work.
How to fix the internet
If we want online discourse to improve, we need to move beyond the big platforms.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.